Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
Yufeng Shi(Memorial Sloan Kettering Cancer Center), Sang Kyun Lim(Southwestern Medical Center), Qiren Liang(The University of Texas Southwestern Medical Center), Swathi V. Iyer(Memorial Sloan Kettering Cancer Center), Hua-Yu Wang(Southwestern Medical Center), Zilai Wang(Memorial Sloan Kettering Cancer Center), Xuanhua Xie(Memorial Sloan Kettering Cancer Center), Daochun Sun(Memorial Sloan Kettering Cancer Center), Yu-Jung Chen(Memorial Sloan Kettering Cancer Center), Viviane Tabar(Memorial Sloan Kettering Cancer Center), Philip H. Gutin(Memorial Sloan Kettering Cancer Center), Noelle S. Williams(Southwestern Medical Center), Jef K. De Brabander(Southwestern Medical Center), Luis F. Parada(Memorial Sloan Kettering Cancer Center)
Cited by 328Open Access